| Original language | English |
|---|---|
| Pages (from-to) | 2071-2074 |
| Number of pages | 4 |
| Journal | Intensive care medicine |
| Volume | 46 |
| Issue number | 11 |
| DOIs |
|
| State | Published - Nov 1 2020 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Intensive care medicine, Vol. 46, No. 11, 01.11.2020, p. 2071-2074.
Research output: Contribution to journal › Comment/debate
TY - JOUR
T1 - Bacterial and fungal superinfections in critically ill patients with COVID-19
AU - Bassetti, Matteo
AU - Kollef, Marin H.
AU - Timsit, Jean Francois
N1 - Funding Information: Outside the submitted work, MB has received funding for scientific advisory boards, travel and speaker honoraria from Angelini, Astellas, AstraZeneca, Basilea, Bayer, BioMérieux, Cidara, Correvio, Cubist, Menarini, Molteni, MSD, Nabriva, Paratek, Pfizer, Roche, Shionogi, Tetraphase, Thermo Fisher, and The Medicine Company. Outside the submitted work, JFT has received fund for advisory boards from Beckton-Dickinson, Gilead, Pfizer, MSD, Nabriva, Medimmune, Paratek, Astellas, Bayer and received fees for giving lectures in symposia for MSD, Pfizer, BioMérieux. JFT research unit received fund for research grants from MSD, Pfizer, and 3M. MHK is supported by the Barnes-Jewish Hospital Foundation. Funding Information: Outside the submitted work, MB has received funding for scientific advisory boards, travel and speaker honoraria from Angelini, Astellas, AstraZeneca, Basilea, Bayer, BioM?rieux, Cidara, Correvio, Cubist, Menarini, Molteni, MSD, Nabriva, Paratek, Pfizer, Roche, Shionogi, Tetraphase, Thermo Fisher, and The Medicine Company. Outside the submitted work, JFT has received fund for advisory boards from Beckton-Dickinson, Gilead, Pfizer, MSD, Nabriva, Medimmune, Paratek, Astellas, Bayer and received fees for giving lectures in symposia for MSD, Pfizer, BioM?rieux. JFT research unit received fund for research grants from MSD, Pfizer, and 3M. MHK is supported by the Barnes-Jewish Hospital Foundation.
PY - 2020/11/1
Y1 - 2020/11/1
UR - http://www.scopus.com/inward/record.url?scp=85090456291&partnerID=8YFLogxK
U2 - 10.1007/s00134-020-06219-8
DO - 10.1007/s00134-020-06219-8
M3 - Comment/debate
C2 - 32902729
AN - SCOPUS:85090456291
SN - 0342-4642
VL - 46
SP - 2071
EP - 2074
JO - Intensive care medicine
JF - Intensive care medicine
IS - 11
ER -